Dermatology Company Galderma’s R&D Locations

Galderma’s five R&D centers are located in France, Sweden, the United States, Switzerland and Japan, and play a key role in discovering and developing innovative medical solutions for the global dermatology market.

Galderma’s five R&D centers are located in France, Sweden, the United States, Switzerland and Japan and are playing a key role in the discovering and developing of innovative medical solutions for the global dermatology market.


Sophia Antipolis, France

Galderma R&D SNC
Les Templiers - 2400, route des Colles - Sophia Antipolis, 06410 Biot - France

The world's largest R&D centre specialised in dermatology:
Located in southeast France, dermatology company Galderma’s Sophia Antipolis facility is the largest laboratory in the world dedicated exclusively to dermatology. Five hundred scientists and support staff work at the centre which hosts all of Galderma's in-house research, pre-clinical and core development (clinical, pharmaceutical and biometric) activities.
Since its opening at the end of 2006,this 19.300 sq metres facility accommodates our scientists with expertise ranging from genomics to proteomics, from high throughput technologies such as screening, chemistry and toxico-genomics to early pharmacokinetics…


Uppsala, Sweden

Q-Med AB
Seminariegatan 21 - visiting address: Fyrisvallsgatan 7 - 75228 Uppsala - Sweden

One of dermatology company Galderma's international sites in Uppsala, Sweden is the Global Aesthetic Centre of Excellence with nearly 400 employees as well as world-class research and manufacturing. The site is responsible for Innovation, Development, Manufacturing and Strategic brand management for aesthetic and corrective treatments. A majority of the products in the Q-Med portfolio is based on the dermatology company’s patented technology, NASHA™, for the production of stabilised non-animal hyaluronic acid.

80 employees at the site are dedicated to Research & Development with a state-of-the-art expertise in understanding, characterisation and modifying of hyaluronic acid.


Princeton, USA

Galderma R&D Inc.
5 Cedar Brook Drive, suite 1 - Cranbury, NJ 08512 - USA

Located in New Jersey, the Princeton centre is focused on clinical development projects with the primary objective of obtaining registration of Galderma's dermatology solutions and products in the US and Canada.

Clinical studies directed by this site are conducted under international clinical harmonisation guidelines and are often used to support regulatory submissions for Galderma’s products around the world.


Tokyo, Japan

Galderma KK
Shinjuku Grand Tower, 34F
8-17-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-6134 -Japan



The R&D team in Tokyo is entirely devoted to the development and registration of new products for the Japanese market, the second largest dermatology market in the world.


Egerkingen, Switzerland

Galderma Spirig
Spirig Pharma AG
Froschackerstrasse 6
4622 Egerkingen – Switzerland

The R&D Self-medication unit in Egerkingen develops new products and maintains marketed products for all key self-medication brands (Cetaphil, Loceryl, Actinica). Research, development and core competences focusing on skin barrier function impairment, as well as sun protection are provided by a team of formulation specialists, clinicians, preclinical experts and project managers.

Galderma’s Self-medication business, one of its manufacturing plants and its Swiss affiliate are also situated in Egerkingen.